Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal, Cona & McDarby vs. Merck, Video Supplement Harvard Case Solution & Analysis

In 2004, pharmaceutical powerhouse Merck withdrew one of its most popular drugs, Vioxx, an arthritis and pain relief drug, from the marketplace and admitted possibly dangerous side effects. Removing an FDA approved drug from the U.S. marketplace due to just-discovered side effects wasn't so uncommon. What was uncommon, however, was that Merck's withdrawal was a voluntary choice by the company after Vioxx had been taken by an estimated 80 million patients during four plus years available on the market. While Merck's selection was initially hailed as an example of Merck known dedication to ethical business practices, some in the medical community instead accused Merck of intentionally keeping Vioxx in the marketplace although it was dangerous. Critics claimed that Merck had put profits ahead of patients and Merck soon faced close to 30,000 product liability suits. This case package consists of an associated case video which happens in the courtroom of a trial against Merck, and a written case, supporting materials that are written.

Using trial footage furnished by Courtroom View Network, this case explores how companies like Merck defend themselves against such claims and the kinds of wrongful conduct alleged. Disc 1: Introduction to the trial & Opening statements Disk 2: Testimony in Plaintiffs' Case Disk 3: Testimony in Merck's Defense Disc 4: Closing Statements, Judge Instructions, Verdicts Disk 5: Review copy of case study, supplementary materials and slides from video demo This content is made to be used in an one-day seminar or equivalent, with pupils having read the written case study and watched Disk 1 before category. This case is particularly well suited for business, medical, and law students. Video and the written materials are sold as a package and are designed to be used collectively. Academic faculty may request a teaching note. Please contact cases_requests@gsb.stanford.edu for permissions to use the written case each time it's taught.

PUBLICATION DATE: January 03, 2010 PRODUCT #: BME11-VID-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal, Cona & McDarby vs. Merck, Video Supplement Case Solution Other Similar Case Solutions like

Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal, Cona & McDarby vs. Merck, Video Supplement

Share This